Olanzapine/samidorphan will lessen the extent or impact of hydromorphone by pharmacodynamic antagonism. Contraindicated. Samidorphan elicits opioid antagonistic outcomes and improves risk of precipitating acute opioid withdrawal in people dependent on opioids. The usage of DILAUDID INJECTION will not be advised for clients having MAOIs or in 14 days of stopping https://helenn604quz6.wikinarration.com/user